These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9771206)

  • 1. Postural changes, dysphagia, and systemic sclerosis.
    Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB
    Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206
    [No Abstract]   [Full Text] [Related]  

  • 2. D-penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis.
    Dourmishev LA; Stomonjakova SR; Dourmishev AL
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):538-9. PubMed ID: 12428861
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient acantholytic dermatosis (Grover's disease) in a patient with progressive systemic sclerosis treated with D-penicillamine.
    Zvulunov A; Grunwald MH; Avinoach I; Halevy S
    Int J Dermatol; 1997 Jun; 36(6):476-7. PubMed ID: 9248901
    [No Abstract]   [Full Text] [Related]  

  • 4. Ankylosing spondylitis and systemic sclerosis: a rare combination.
    Ouédraogo DD; Palazzo E; Nlomé-Nzé M; Somogyi-Demerjian N; Meyer O
    Joint Bone Spine; 2009 May; 76(3):290-2. PubMed ID: 19372061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine.
    Boehler A; Vogt P; Speich R; Weder W; Russi EW
    Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary involvement in systemic sclerosis due to therapy and as a complication.
    Chiappini F; Zoli A; Maugeri L
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):111-3. PubMed ID: 16128227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials for the treatment of systemic sclerosis/scleroderma.
    Varga J; Ponor I
    Curr Rheumatol Rep; 1999 Oct; 1(1):13-4. PubMed ID: 11123008
    [No Abstract]   [Full Text] [Related]  

  • 12. [D-penicillamine therapy of chronic polyarthritis].
    Günther R; Gabl F; Knapp E
    Z Rheumaforsch; 1973; 32(7):313-25. PubMed ID: 4741805
    [No Abstract]   [Full Text] [Related]  

  • 13. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
    Derk CT; Jimenez SA
    J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis.
    Nishikai M; Funatsu Y; Homma M
    Arch Dermatol; 1974 Aug; 110(2):253-5. PubMed ID: 4853253
    [No Abstract]   [Full Text] [Related]  

  • 15. [D-penicillamine: an outdated cure for systemic scleroderma?].
    Marie I; Lévesque H; Courtois H
    Rev Med Interne; 1999 Dec; 20(12):1077-81. PubMed ID: 10635068
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of myasthenia gravis caused by D-penicillamine therapy].
    Susa S; Akiba J; Kurimura M; Kurita K; Daimon M; Manaka H; Yamatani K; Kato T
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2513-5. PubMed ID: 9922674
    [No Abstract]   [Full Text] [Related]  

  • 17. D-penicillamine in systemic sclerosis? Yes!
    Medsger TA; Lucas M; Wildy KS; Baker C
    Scand J Rheumatol; 2001; 30(4):192-4. PubMed ID: 11578011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
    Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
    Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapies for systemic sclerosis.
    Denton CP; Black CM
    Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851
    [No Abstract]   [Full Text] [Related]  

  • 20. Penicillamine for systemic sclerosis?
    Drug Ther Bull; 1974 Sep; 12(19):75-6. PubMed ID: 4469492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.